vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and LIGHTPATH TECHNOLOGIES INC (LPTH). Click either name above to swap in a different company.

LIGHTPATH TECHNOLOGIES INC is the larger business by last-quarter revenue ($16.4M vs $9.2M, roughly 1.8× Foghorn Therapeutics Inc.). LIGHTPATH TECHNOLOGIES INC runs the higher net margin — -57.5% vs -234.3%, a 176.8% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 120.2%). Over the past eight quarters, LIGHTPATH TECHNOLOGIES INC's revenue compounded faster (45.7% CAGR vs 35.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

LightPath Technologies Inc designs, manufactures and distributes high-precision optical components and assemblies, including aspheric lenses, infrared optics, and fiber optic products. It serves global clients across industrial automation, aerospace, defense, medical imaging, and telecommunications sectors.

FHTX vs LPTH — Head-to-Head

Bigger by revenue
LPTH
LPTH
1.8× larger
LPTH
$16.4M
$9.2M
FHTX
Growing faster (revenue YoY)
FHTX
FHTX
+103.5% gap
FHTX
223.8%
120.2%
LPTH
Higher net margin
LPTH
LPTH
176.8% more per $
LPTH
-57.5%
-234.3%
FHTX
Faster 2-yr revenue CAGR
LPTH
LPTH
Annualised
LPTH
45.7%
35.3%
FHTX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FHTX
FHTX
LPTH
LPTH
Revenue
$9.2M
$16.4M
Net Profit
$-21.7M
$-9.4M
Gross Margin
36.8%
Operating Margin
-258.2%
-52.6%
Net Margin
-234.3%
-57.5%
Revenue YoY
223.8%
120.2%
Net Profit YoY
-11.1%
-260.1%
EPS (diluted)
$-0.35
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
LPTH
LPTH
Q4 25
$9.2M
$16.4M
Q3 25
$8.2M
$15.1M
Q2 25
$7.6M
$12.2M
Q1 25
$6.0M
$9.2M
Q4 24
$2.9M
$7.4M
Q3 24
$7.8M
$8.4M
Q2 24
$6.9M
$8.6M
Q1 24
$5.0M
$7.7M
Net Profit
FHTX
FHTX
LPTH
LPTH
Q4 25
$-21.7M
$-9.4M
Q3 25
$-15.8M
$-2.9M
Q2 25
$-17.9M
$-7.1M
Q1 25
$-18.8M
$-3.6M
Q4 24
$-19.5M
$-2.6M
Q3 24
$-19.1M
$-1.6M
Q2 24
$-23.0M
$-2.4M
Q1 24
$-25.0M
$-2.6M
Gross Margin
FHTX
FHTX
LPTH
LPTH
Q4 25
36.8%
Q3 25
29.8%
Q2 25
22.0%
Q1 25
29.1%
Q4 24
26.0%
Q3 24
33.9%
Q2 24
29.2%
Q1 24
20.9%
Operating Margin
FHTX
FHTX
LPTH
LPTH
Q4 25
-258.2%
-52.6%
Q3 25
-226.9%
-16.6%
Q2 25
-279.2%
-38.0%
Q1 25
-385.0%
-36.3%
Q4 24
-840.5%
-33.5%
Q3 24
-305.5%
-16.4%
Q2 24
-386.6%
-25.6%
Q1 24
-558.3%
-33.6%
Net Margin
FHTX
FHTX
LPTH
LPTH
Q4 25
-234.3%
-57.5%
Q3 25
-194.4%
-19.2%
Q2 25
-237.3%
-57.8%
Q1 25
-316.4%
-39.1%
Q4 24
-682.9%
-35.2%
Q3 24
-244.9%
-19.3%
Q2 24
-333.6%
-27.3%
Q1 24
-495.4%
-33.7%
EPS (diluted)
FHTX
FHTX
LPTH
LPTH
Q4 25
$-0.35
$-0.20
Q3 25
$-0.25
$-0.07
Q2 25
$-0.28
$0.19
Q1 25
$-0.30
$-0.44
Q4 24
$-0.23
$-0.07
Q3 24
$-0.31
$-0.04
Q2 24
$-0.45
$-0.15
Q1 24
$-0.59
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
LPTH
LPTH
Cash + ST InvestmentsLiquidity on hand
$80.9M
$73.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-108.5M
$77.9M
Total Assets
$198.1M
$148.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
LPTH
LPTH
Q4 25
$80.9M
$73.6M
Q3 25
$89.3M
Q2 25
$72.6M
$4.9M
Q1 25
$61.0M
Q4 24
$55.5M
Q3 24
$57.7M
Q2 24
$138.9M
Q1 24
$79.3M
Total Debt
FHTX
FHTX
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$535.0K
Q1 24
$599.4K
Stockholders' Equity
FHTX
FHTX
LPTH
LPTH
Q4 25
$-108.5M
$77.9M
Q3 25
$-89.7M
$21.4M
Q2 25
$-76.7M
$15.6M
Q1 25
$-61.7M
$15.7M
Q4 24
$-45.5M
$26.7M
Q3 24
$-28.3M
$29.4M
Q2 24
$-14.3M
$30.2M
Q1 24
$-97.5M
$31.7M
Total Assets
FHTX
FHTX
LPTH
LPTH
Q4 25
$198.1M
$148.6M
Q3 25
$205.0M
$87.3M
Q2 25
$226.2M
$81.5M
Q1 25
$258.7M
$81.4M
Q4 24
$284.0M
$45.8M
Q3 24
$308.4M
$48.4M
Q2 24
$328.6M
$48.1M
Q1 24
$255.0M
$49.7M
Debt / Equity
FHTX
FHTX
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
LPTH
LPTH
Operating Cash FlowLast quarter
$-22.3M
$2.8M
Free Cash FlowOCF − Capex
$2.0M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
0.0%
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
LPTH
LPTH
Q4 25
$-22.3M
$2.8M
Q3 25
$-18.9M
$-1.1M
Q2 25
$-21.0M
$-2.6M
Q1 25
$-24.0M
$-3.2M
Q4 24
$-24.5M
$-737.4K
Q3 24
$-21.0M
$-1.7M
Q2 24
$-25.5M
$64.7K
Q1 24
$-29.3M
$-394.2K
Free Cash Flow
FHTX
FHTX
LPTH
LPTH
Q4 25
$2.0M
Q3 25
$-1.2M
Q2 25
$-21.0M
$-3.3M
Q1 25
$-24.0M
$-3.7M
Q4 24
$-25.0M
$-817.8K
Q3 24
$-21.3M
$-1.8M
Q2 24
$-25.6M
$-225.5K
Q1 24
$-29.4M
$-802.5K
FCF Margin
FHTX
FHTX
LPTH
LPTH
Q4 25
12.0%
Q3 25
-8.1%
Q2 25
-278.2%
-27.3%
Q1 25
-403.2%
-40.0%
Q4 24
-875.3%
-11.0%
Q3 24
-273.0%
-21.2%
Q2 24
-371.0%
-2.6%
Q1 24
-583.1%
-10.4%
Capex Intensity
FHTX
FHTX
LPTH
LPTH
Q4 25
0.0%
5.3%
Q3 25
0.0%
0.5%
Q2 25
0.3%
5.6%
Q1 25
0.5%
4.6%
Q4 24
16.8%
1.1%
Q3 24
4.0%
0.9%
Q2 24
0.2%
3.4%
Q1 24
2.0%
5.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FHTX
FHTX

Segment breakdown not available.

LPTH
LPTH

Other$7.9M48%
Infrared Components$5.0M31%
Visible Components$3.4M21%

Related Comparisons